Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Eterna Therapeutics Inc. | President and CEO, Director | Stock Option (right to buy) | 132K | Jan 12, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ERNA | Eterna Therapeutics Inc. | Jan 12, 2023 | 1 | $0 | 4 | Jan 13, 2023 | President and CEO, Director |
ERNA | Brooklyn ImmunoTherapeutics, Inc. | Aug 1, 2022 | 1 | $0 | 4 | Aug 3, 2022 | Interim President and CEO, Director |
ERNA | Brooklyn ImmunoTherapeutics, Inc. | May 26, 2022 | 0 | $0 | 3 | Jun 1, 2022 | Interim President and CEO |